对于治疗耐药抑郁症的短期胺使用没有反应
Michał Walaszek1, Wiesław Jerzy Cubała2, Zofia Kachlik2
1Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, ul. Smoluchowskiego 17, Gdańsk, 80-214, Poland. michal.walaszek@gumed.edu.pl.
Pharmacological reports : PR
|April 30, 2025
概括
在治疗耐药性抑郁症 (TRD) 中,胺酸不响应与更少的物质使用障碍和并发症有关. 了解这些预测因素可以优化对主要抑郁症治疗的胺治疗.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 胺作为治疗耐药抑郁症 (TRD) 的快速抗抑郁药物显示出希望.
- 在TRD患者中,胺酸不响应的预测因子尚未确定.
- 这项研究调查了与胺素无反应相关的社会人口统计学和临床特征.
研究的目的:
- 确定TRD患者对胺治疗没有反应的预测因子.
- 描述社会人口统计学和临床特征,区分胺胺反应者和非反应者.
- 为临床决策和TRD管理的未来研究提供信息.
主要方法:
- 一个自然主义的观察研究的后期分析.
- 包括40名患有治疗耐药性重度抑郁症的住院患者.
- 使用蒙哥马利-阿斯伯格抑郁评分表 (MADRS) 分数评估社会人口统计学和临床特征.
- 在4周内短期服用胺 (IV 0.5 mg/kg;口服2.0或2.5 mg/kg).
主要成果:
- 75%的患者 (30/40) 被归类为没有对胺反应的患者.
- 非响应者报告了以前物质使用障碍 (SUD) 的比率明显较低 (53.3%与100%相比;p=0.0075).
- 非响应者与响应者相比,精神病并发症也较少 (p=0.0381).
结论:
- 较低的SUD率和较少的精神伴随性疾病是TRD患者的特征,这些患者对胺不反应.
- 这些发现表明,传统TRD风险因素的较高负担可能不会阻碍胺的疗效.
- 早期识别不响应者对于优化治疗和指导未来TRD研究至关重要.
相关概念视频
01:30Electroconvulsive Therapy
16
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
16
01:26Psychosis: Goals of Pharmacotherapy
95
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
95
01:23Antidepressant Drugs: MAOIs and Other Agents
159
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
159
01:03Long-term Depression
2.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.4K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
97
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
97
01:24Parenteral Anesthetics: Overview
80
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
80